This is a clinically supported reason to switch from Wegovy to Mounjaro if Wegovy produces inadequate results
Retatrutide is in Phase 3 trials for type 2 diabetes (TRANSCEND-T2D program), obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease in patients with type 2 diabetes, knee osteoarthritis, and cardiovascular outcomes [1][8][10][11]
The doctors feedback was received within a day, recommending a starting dose that matched my needs
TSPO directly interacts with the autophagy receptor p62, thus interfering with the autophagy degradation of p62
Probiotics may be shelf-stable (stored at room temperature), or they may require refrigeration
Confirm any figure on the provider's own site before committing